Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Why Breast Cancer Risk Models Fail: The Case of Lobular Carcinoma In Situ.

Euhus DM.

Ann Surg Oncol. 2019 Sep 27. doi: 10.1245/s10434-019-07875-x. [Epub ahead of print] No abstract available.

PMID:
31562599
2.

Survival and Disease Recurrence Rates among Breast Cancer Patients following Mastectomy with or without Breast Reconstruction.

Siotos C, Naska A, Bello RJ, Uzosike A, Orfanos P, Euhus DM, Manahan MA, Cooney CM, Lagiou P, Rosson GD.

Plast Reconstr Surg. 2019 Aug;144(2):169e-177e. doi: 10.1097/PRS.0000000000005798.

PMID:
31348330
3.

Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons.

Manahan ER, Kuerer HM, Sebastian M, Hughes KS, Boughey JC, Euhus DM, Boolbol SK, Taylor WA.

Ann Surg Oncol. 2019 Oct;26(10):3025-3031. doi: 10.1245/s10434-019-07549-8. Epub 2019 Jul 24.

4.

Germline Genetic Testing: What the Breast Surgeon Needs to Know.

Plichta JK, Sebastian ML, Smith LA, Menendez CS, Johnson AT, Bays SM, Euhus DM, Clifford EJ, Jalali M, Kurtzman SH, Taylor WA, Hughes KS.

Ann Surg Oncol. 2019 Jul;26(7):2184-2190. doi: 10.1245/s10434-019-07341-8. Epub 2019 Apr 2.

PMID:
30941656
5.

Change in health-related quality of life in older women after diagnosis of a small breast cancer.

Euhus DM, Addae JK, Snyder CF, Canner JK.

Cancer. 2019 Jun 1;125(11):1807-1814. doi: 10.1002/cncr.31993. Epub 2019 Feb 1.

PMID:
30707774
6.

Surgeon Re-Excision Rates after Breast-Conserving Surgery: A Measure of Low-Value Care.

Kaczmarski K, Wang P, Gilmore R, Overton HN, Euhus DM, Jacobs LK, Habibi M, Camp M, Weiss MJ, Makary MA.

J Am Coll Surg. 2019 Apr;228(4):504-512.e2. doi: 10.1016/j.jamcollsurg.2018.12.043. Epub 2019 Jan 29.

PMID:
30703538
7.

The Use of Tumescent Technique in Mastectomy and Related Complications: A Meta-Analysis.

Siotos C, Aston JW, Euhus DM, Seal SM, Manahan MA, Rosson GD.

Plast Reconstr Surg. 2019 Jan;143(1):39-48. doi: 10.1097/PRS.0000000000005100.

PMID:
30589774
8.

Selecting the Right Tumors for Genomic Testing.

Euhus DM.

Ann Surg Oncol. 2019 Feb;26(2):313-314. doi: 10.1245/s10434-018-7036-y. Epub 2018 Nov 12. No abstract available.

PMID:
30421060
9.

A comparison of trends in operative approach and postoperative outcomes for colorectal cancer surgery.

Addae JK, Gani F, Fang SY, Wick EC, Althumairi AA, Efron JE, Canner JK, Euhus DM, Schneider EB.

J Surg Res. 2017 Feb;208:111-120. doi: 10.1016/j.jss.2016.09.019. Epub 2016 Sep 17.

PMID:
27993198
10.

Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.

Hunt KK, Euhus DM, Boughey JC, Chagpar AB, Feldman SM, Hansen NM, Kulkarni SA, McCready DR, Mamounas EP, Wilke LG, Van Zee KJ, Morrow M.

Ann Surg Oncol. 2017 Feb;24(2):375-397. doi: 10.1245/s10434-016-5688-z. Epub 2016 Dec 8. Review.

PMID:
27933411
11.

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.

Visvanathan K, Fackler MS, Zhang Z, Lopez-Bujanda ZA, Jeter SC, Sokoll LJ, Garrett-Mayer E, Cope LM, Umbricht CB, Euhus DM, Forero A, Storniolo AM, Nanda R, Lin NU, Carey LA, Ingle JN, Sukumar S, Wolff AC.

J Clin Oncol. 2017 Mar;35(7):751-758. doi: 10.1200/JCO.2015.66.2080. Epub 2016 Nov 21.

12.

Choosing Bilateral Mastectomy.

Euhus DM.

Breast J. 2016 Nov;22(6):605-606. doi: 10.1111/tbj.12654. No abstract available.

PMID:
27870336
13.

Invasive Breast Cancer Preferably and Predominantly Occurs at the Interface Between Fibroglandular and Adipose Tissue.

Zhu W, Harvey S, Macura KJ, Euhus DM, Artemov D.

Clin Breast Cancer. 2017 Feb;17(1):e11-e18. doi: 10.1016/j.clbc.2016.07.009. Epub 2016 Jul 28.

14.

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.

Rugo HS, Olopade OI, DeMichele A, Yau C, van 't Veer LJ, Buxton MB, Hogarth M, Hylton NM, Paoloni M, Perlmutter J, Symmans WF, Yee D, Chien AJ, Wallace AM, Kaplan HG, Boughey JC, Haddad TC, Albain KS, Liu MC, Isaacs C, Khan QJ, Lang JE, Viscusi RK, Pusztai L, Moulder SL, Chui SY, Kemmer KA, Elias AD, Edmiston KK, Euhus DM, Haley BB, Nanda R, Northfelt DW, Tripathy D, Wood WC, Ewing C, Schwab R, Lyandres J, Davis SE, Hirst GL, Sanil A, Berry DA, Esserman LJ; I-SPY 2 Investigators.

N Engl J Med. 2016 Jul 7;375(1):23-34. doi: 10.1056/NEJMoa1513749.

15.

Adaptive Randomization of Neratinib in Early Breast Cancer.

Park JW, Liu MC, Yee D, Yau C, van 't Veer LJ, Symmans WF, Paoloni M, Perlmutter J, Hylton NM, Hogarth M, DeMichele A, Buxton MB, Chien AJ, Wallace AM, Boughey JC, Haddad TC, Chui SY, Kemmer KA, Kaplan HG, Isaacs C, Nanda R, Tripathy D, Albain KS, Edmiston KK, Elias AD, Northfelt DW, Pusztai L, Moulder SL, Lang JE, Viscusi RK, Euhus DM, Haley BB, Khan QJ, Wood WC, Melisko M, Schwab R, Helsten T, Lyandres J, Davis SE, Hirst GL, Sanil A, Esserman LJ, Berry DA; I-SPY 2 Investigators.

N Engl J Med. 2016 Jul 7;375(1):11-22. doi: 10.1056/NEJMoa1513750.

16.

New Insights into the Surgical Management of Breast Cancer.

Euhus DM.

Semin Radiat Oncol. 2016 Jan;26(1):25-36. doi: 10.1016/j.semradonc.2015.09.007. Epub 2015 Sep 14. Review.

PMID:
26617207
17.

Contralateral Prophylactic Mastectomy: Challenging Considerations for the Surgeon.

Angelos P, Bedrosian I, Euhus DM, Herrmann VM, Katz SJ, Pusic A.

Ann Surg Oncol. 2015 Oct;22(10):3208-12. doi: 10.1245/s10434-015-4758-y. Epub 2015 Aug 11.

18.

Risk-reducing mastectomy for BRCA gene mutation carriers.

Euhus DM.

Ann Surg Oncol. 2015 Sep;22(9):2807-9. doi: 10.1245/s10434-015-4537-9. Epub 2015 Mar 28. No abstract available.

PMID:
25821000
19.

Breast cancer prevention.

Euhus DM, Diaz J.

Breast J. 2015 Jan-Feb;21(1):76-81. doi: 10.1111/tbj.12352. Epub 2014 Nov 20.

PMID:
25413630
20.

Are axillary lymph nodes still relevant in breast cancer ?

Euhus DM.

Ann Surg Oncol. 2014 Dec;21(13):4051-3. doi: 10.1245/s10434-014-3994-x. Epub 2014 Aug 26. No abstract available.

PMID:
25155394
21.

Aggressive estrogen-receptor-positive breast cancer arising in patients with elevated body mass index.

Santa-Maria CA, Yan J, Xie XJ, Euhus DM.

Int J Clin Oncol. 2015 Apr;20(2):317-23. doi: 10.1007/s10147-014-0712-4. Epub 2014 Jun 10.

22.

Commentary on the Canadian National Breast Screening study.

Van Zee KJ, Hansen NM, Barrio AV, Connor CS, Danforth DN, Euhus DM, Kulkarni SA, McCready DR, McLaughlin S, Wilke LG.

Ann Surg Oncol. 2014 Dec;21(13):4397-8. doi: 10.1245/s10434-014-3789-0. Epub 2014 May 24.

PMID:
24859935
23.

27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.

Wu Q, Ishikawa T, Sirianni R, Tang H, McDonald JG, Yuhanna IS, Thompson B, Girard L, Mineo C, Brekken RA, Umetani M, Euhus DM, Xie Y, Shaul PW.

Cell Rep. 2013 Nov 14;5(3):637-45. doi: 10.1016/j.celrep.2013.10.006. Epub 2013 Nov 7.

24.

The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience.

Mauer CB, Pirzadeh-Miller SM, Robinson LD, Euhus DM.

Genet Med. 2014 May;16(5):407-12. doi: 10.1038/gim.2013.160. Epub 2013 Oct 10.

PMID:
24113346
25.

Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers.

Bey EA, Reinicke KE, Srougi MC, Varnes M, Anderson VE, Pink JJ, Li LS, Patel M, Cao L, Moore Z, Rommel A, Boatman M, Lewis C, Euhus DM, Bornmann WG, Buchsbaum DJ, Spitz DR, Gao J, Boothman DA.

Mol Cancer Ther. 2013 Oct;12(10):2110-20. doi: 10.1158/1535-7163.MCT-12-0962. Epub 2013 Jul 24.

26.

Genetic predisposition syndromes and their management.

Euhus DM, Robinson L.

Surg Clin North Am. 2013 Apr;93(2):341-62. doi: 10.1016/j.suc.2013.01.005. Epub 2013 Feb 11. Review.

PMID:
23464690
27.

The clinical consequences of hemizygosity across 2 MB of 10q23 are restricted to Cowden syndrome.

Lewis CM, Bu D, Sarode V, Robinson L, Wilson KS, Viscusi RK, Eng C, Euhus DM.

Breast Cancer Res Treat. 2012 Dec;136(3):911-8. doi: 10.1007/s10549-012-2322-z. Epub 2012 Nov 7.

PMID:
23132533
28.

Diabetes, metformin, and breast cancer in postmenopausal women.

Chlebowski RT, McTiernan A, Wactawski-Wende J, Manson JE, Aragaki AK, Rohan T, Ipp E, Kaklamani VG, Vitolins M, Wallace R, Gunter M, Phillips LS, Strickler H, Margolis K, Euhus DM.

J Clin Oncol. 2012 Aug 10;30(23):2844-52. doi: 10.1200/JCO.2011.39.7505. Epub 2012 Jun 11.

29.

Evaluation of a hydrogel based breast biopsy marker (HydroMARK®) as an alternative to wire and radioactive seed localization for non-palpable breast lesions.

Klein RL, Mook JA, Euhus DM, Rao R, Wynn RT, Eastman AB, Leitch AM.

J Surg Oncol. 2012 May;105(6):591-4. doi: 10.1002/jso.22146. Epub 2011 Nov 17.

PMID:
22095610
30.

Paracrine and endocrine effects of adipose tissue on cancer development and progression.

Park J, Euhus DM, Scherer PE.

Endocr Rev. 2011 Aug;32(4):550-70. doi: 10.1210/er.2010-0030. Epub 2011 Jun 2. Review.

31.

New insights into the prevention and treatment of familial breast cancer.

Euhus DM.

J Surg Oncol. 2011 Mar 15;103(4):294-8. doi: 10.1002/jso.21664. Review.

PMID:
21337561
32.

The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing.

Murphy CD, Lee JM, Drohan B, Euhus DM, Kopans DB, Gadd MA, Rafferty EA, Specht MC, Smith BL, Hughes KS.

Cancer. 2008 Dec 1;113(11):3116-20. doi: 10.1002/cncr.23913.

33.

DNA methylation in benign breast epithelium in relation to age and breast cancer risk.

Euhus DM, Bu D, Milchgrub S, Xie XJ, Bian A, Leitch AM, Lewis CM.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1051-9. doi: 10.1158/1055-9965.EPI-07-2582.

34.

RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers.

Gao B, Xie XJ, Huang C, Shames DS, Chen TT, Lewis CM, Bian A, Zhang B, Olopade OI, Garber JE, Euhus DM, Tomlinson GE, Minna JD.

Cancer Res. 2008 Jan 1;68(1):22-5. doi: 10.1158/0008-5472.CAN-07-5183.

35.

Validity of models for predicting BRCA1 and BRCA2 mutations.

Parmigiani G, Chen S, Iversen ES Jr, Friebel TM, Finkelstein DM, Anton-Culver H, Ziogas A, Weber BL, Eisen A, Malone KE, Daling JR, Hsu L, Ostrander EA, Peterson LE, Schildkraut JM, Isaacs C, Corio C, Leondaridis L, Tomlinson G, Amos CI, Strong LC, Berry DA, Weitzel JN, Sand S, Dutson D, Kerber R, Peshkin BN, Euhus DM.

Ann Intern Med. 2007 Oct 2;147(7):441-50.

36.

Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk.

Euhus DM, Bu D, Ashfaq R, Xie XJ, Bian A, Leitch AM, Lewis CM.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1812-21.

37.

Primary breast tumor characteristics predicting aggressive nodal involvement.

Ma AM, Bowling M, Leitch M, Rao R, Euhus DM.

Am J Surg. 2007 Oct;194(4):474-6.

PMID:
17826058
38.

Role of physical activity in modulating breast cancer risk as defined by APC and RASSF1A promoter hypermethylation in nonmalignant breast tissue.

Coyle YM, Xie XJ, Lewis CM, Bu D, Milchgrub S, Euhus DM.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):192-6.

39.

A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.

Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N, Jiang A, Perou CM, Kim YH, Pollack JR, Fong KM, Lam CL, Wong M, Shyr Y, Nanda R, Olopade OI, Gerald W, Euhus DM, Shay JW, Gazdar AF, Minna JD.

PLoS Med. 2006 Dec;3(12):e486.

40.

An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer.

Bu D, Tomlinson G, Lewis CM, Zhang C, Kildebeck E, Euhus DM.

Breast Cancer Res Treat. 2006 Oct;99(3):257-65. Epub 2006 Apr 5.

PMID:
16596326
41.

Telomerase immortalization of human mammary epithelial cells derived from a BRCA2 mutation carrier.

Lewis CM, Herbert BS, Bu D, Halloway S, Beck A, Shadeo A, Zhang C, Ashfaq R, Shay JW, Euhus DM.

Breast Cancer Res Treat. 2006 Sep;99(1):103-15. Epub 2006 Mar 16.

PMID:
16541310
42.

Breast cancer prevention in the 21st century: defining the challenge.

Euhus DM.

Breast J. 2006 Mar-Apr;12(2):97-8. No abstract available.

PMID:
16509832
43.

Characterization of BRCA1 and BRCA2 mutations in a large United States sample.

Chen S, Iversen ES, Friebel T, Finkelstein D, Weber BL, Eisen A, Peterson LE, Schildkraut JM, Isaacs C, Peshkin BN, Corio C, Leondaridis L, Tomlinson G, Dutson D, Kerber R, Amos CI, Strong LC, Berry DA, Euhus DM, Parmigiani G.

J Clin Oncol. 2006 Feb 20;24(6):863-71.

44.

An ecological study of the association of environmental chemicals on breast cancer incidence in Texas.

Coyle YM, Hynan LS, Euhus DM, Minhajuddin AT.

Breast Cancer Res Treat. 2005 Jul;92(2):107-14.

PMID:
15986119
45.

A variant of DNA polymerase beta is not cancer specific.

Bu D, Cler LR, Lewis CM, Euhus DM.

J Invest Surg. 2004 Nov-Dec;17(6):327-31.

PMID:
15764500
46.

Reproducibility of cytologic atypia in repeat nipple duct lavage.

Johnson-Maddux A, Ashfaq R, Cler L, Naftalis E, Leitch AM, Hoover S, Euhus DM.

Cancer. 2005 Mar 15;103(6):1129-36.

47.

Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk.

Lewis CM, Cler LR, Bu DW, Zöchbauer-Müller S, Milchgrub S, Naftalis EZ, Leitch AM, Minna JD, Euhus DM.

Clin Cancer Res. 2005 Jan 1;11(1):166-72.

48.

Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy.

Stadler RF, Gregorcyk SG, Euhus DM, Place RJ, Huber PJ, Simmang CL.

Dis Colon Rectum. 2004 Aug;47(8):1305-9.

PMID:
15484343
49.

Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers.

Virmani A, Rathi A, Heda S, Sugio K, Lewis C, Tonk V, Takahashi T, Roth JA, Minna JD, Euhus DM, Gazdar AF.

Int J Cancer. 2003 Nov 10;107(3):341-5.

50.

Supplemental Content

Loading ...
Support Center